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Haemophilus influenzae type b is a common cause of invasive bacterial disease, especially among children in
underdeveloped countries. The type b polysaccharide capsule is a polymer of ribose and ribitol-5-phosphate
and is a critical determinant of virulence. Expression of the type b capsule is dependent upon the cap b locus,
which consists of three functionally distinct regions, designated regions 1 to 3. Region 3 contains the hcsA and
hcsB genes, which share significant homology with genes that have been implicated in encapsulation in other
pathogenic bacteria but have unclear functions. In this study, we inactivated hcsA alone, hcsB alone, and both
hcsA and hcsB together and examined the effects of these mutations on polysaccharide transport and bacterial
virulence properties. Inactivation of hcsA alone resulted in accumulation of polysaccharide in the periplasm
and a partial decrease in surface-associated polysaccharide, whereas inactivation of hcsB alone or of both hcsA
and hcsB together resulted in accumulation of polysaccharide in the periplasm and complete loss of surface-
associated polysaccharide. All mutations eliminated serum resistance and abrogated bacteremia and mortality
in neonatal rats. These results indicate that the hcsA and hcsB gene products have complementary functions
involved in the transport of polysaccharide across the outer membrane and are essential for virulence.
Polysaccharide capsules are common cell surface compo-
nents in bacterial pathogens that cause systemic disease. Based
on in vitro studies, it is known that polysaccharide capsules
mediate resistance to important host defense mechanisms, in-
cluding phagocytosis and complement-mediated killing. In ad-
dition, capsules may prevent desiccation in the environment,
potentially facilitating transmission between hosts. Consistent
with these observations, genetically defined nonencapsulated
mutants of Streptococcus spp., Actinobacillus pleuropneumo-
niae, Klebsiella pneumoniae, Staphylococcus aureus, Pasteurella
multocida, and Haemophilus influenzae have reduced virulence
in animal models (3, 11, 20, 24, 36, 39, 44, 45).
Bacterial capsules are long polysaccharide chains consisting
of smaller repeating units. The composition of these repeating
units varies among bacterial species and is usually distinct
among different serotypes of the same species. Capsular poly-
saccharide biosynthesis occurs in the cytoplasm, and the result-
ing polysaccharide is then transported across the cytoplasmic
membrane into the periplasm and then across the outer mem-
brane to the bacterial surface. Typically, capsules are substi-
tuted with phospholipids at the reducing end of the polysac-
charide chains (14, 21, 30, 33). According to the prevailing
model, lipidation of capsular polysaccharide is required for
transport across the inner membrane and possibly for anchor-
ing to the outer membrane (30).
Encapsulated strains of H. influenzae are an important cause
of sepsis, meningitis, epiglottitis, and septic arthritis in young
children, especially in underdeveloped countries where vacci-
nation rates are low (26). These strains are characterized by
the presence of one of six structurally and serologically distinct
polysaccharide capsules, referred to as serotypes a through f
(28). Type b isolates are most common and express a capsule
that is a polymer of ribose and ribitol-5-phosphate (polyribo-
sylribitolphosphate [PRP]) (9). The genes responsible for the
biosynthesis and surface expression of the type b capsule are
located in the cap b locus, which contains three functionally
distinct regions (19), similar to capsulation loci in other bac-
teria. Most isolates contain a partial tandem duplication of the
cap b locus, with the two copies separated by a 1.2-kb bridge
segment and flanked by IS1016 elements.
The three functionally distinct regions in the cap b locus are
referred to as regions 1 to 3. Region 1 contains genes desig-
nated bexA, bexB, bexC, and bexD and encodes an ABC trans-
porter system involved in the export of capsular polysaccharide
to the bacterial surface (18). Region 2 contains genes currently
designated orf1 to orf4 and encodes enzymes involved in bio-
synthesis of ribose-ribitol-5-phosphate disaccharide subunits
(41). Region 3 contains genes referred to as hcsA and hcsB,
which share significant homology with genes in a number of
other encapsulated pathogens, including Neisseria meningitidis
(lipA and lipB), Escherichia coli K1 and E. coli K5 (kpsC and
kpsS), Mannheimia (Pasteurella) haemolytica (wbrA and wbrB),
P. multocida A:1 (phyA and phyB), P. multocida B:2 (wcbA and
wcbO), Burkholderia mallei, and Burkholderia pseudomallei (4,
7, 10, 13, 22, 29, 32, 34). Overall, the hcsA and lipA gene
products are 60.4% identical, and the hcsB and lipB gene
products are 55.1% identical. Based on analysis of mutations in
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the N. meningitidis lipA and lipB genes, it appears that lipA and
lipB play a role in surface localization and possibly lipidation of
capsular polysaccharide, although published reports are con-
flicting (13, 40). Whether hcsA and hcsB have functions like
those of lipA and lipB remains unclear.
In this study, we inactivated the H. influenzae type b hcsA
and hcsB genes and examined the resulting mutants for poly-
saccharide transport, polysaccharide lipidation, and virulence
properties. Our results established that hcsA and hcsB have
complementary functions involved in the transport of the se-
rotype b polysaccharide across the outer membrane and are
essential for in vitro serum resistance and for virulence in
neonatal rats. We found no evidence that hcsA and hcsB play
a role in polysaccharide lipidation.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. H. influenzae strain Eagan
is a type b clinical isolate that was originally isolated from a child with meningitis
and has a partial duplication of the cap b locus, like most type b isolates (35). H.
influenzae strain Rd is a longtime laboratory strain and is a spontaneous capsule-
deficient mutant of a type d isolate, containing an IS1016 element but no cap
gene (12). H. influenzae strain RM135 is a transformant of strain Rd that harbors
a single copy of the cap b locus and expresses the type b capsule (47). E. coli
DH5 has been previously described (15).
The plasmid pUC18K carries a kanamycin resistance cassette from Enterococ-
cus faecalis and was a generous gift from Philippe Sansonetti (Pasteur Institute,
Paris, France) (23). The plasmid pUC4K carries the kanamycin resistance cas-
sette from Tn903 and was obtained from Pharmacia (43). The plasmids pUC19
and pACYC184 were obtained from New England Biolabs and have been de-
scribed previously (6, 46).
H. influenzae strains were grown in brain heart infusion (BHI) broth supple-
mented with hemin and NAD, on BHI agar supplemented with NAD and hemin
(BHI-DB agar), or on chocolate agar, as described previously (2, 37). E. coli
strains were grown on Luria-Bertani (LB) agar or in LB broth. Antibiotic con-
centrations were as follows: for H. influenzae, kanamycin at 55 g/ml and chlor-
amphenicol at 2 g/ml, and for E. coli, kanamycin at 50 g/ml and ampicillin at
100 g/ml.
General molecular techniques. DNA ligations, restriction endonuclease diges-
tions, gel electrophoresis, and PCR were performed according to standard tech-
niques (31). Plasmids were introduced into E. coli by chemical transformation
(31). Linearized DNA was introduced into H. influenzae made competent using
the M-IV method of transformation (16).
Construction of hcsA and hcsB mutants. To create an hcsA null mutant without
affecting the hcsB gene downstream, we generated an in-frame deletion in hcsA,
leaving the remainder of region 3 intact. To prepare this construct, we cloned the
hcsA and hcsB genes and flanking sequence into pUC19, ligating three separate
PCR-amplified fragments. The PCR primers were designed to create BamHI sites
on both sides of hcsA, making it possible to excise hcsA and preserve the correct
reading frame for hcsB. To allow selection of transformants carrying this con-
struct, the kanamycin cassette from pUC4K was introduced into a unique SalI
site in the IS1016 element downstream of the hcsB gene. As a control, an
analogous construct containing wild-type region 3 and a kanamycin cassette in
the IS1016 element was generated.
To create an hcsB null mutant, we generated PCR fragments corresponding to
the 5 and 3 ends of hcsB and cloned these fragments into pUC19. The PCR
primers were designed to create a BamHI site at the point of fusion of the 5 and
3 fragments, making it possible to insert the kanamycin cassette from pUC4K
and interrupt the hcsB gene.
To create an hcsA hcsB double mutant, we began by generating two separate
plasmids. As a first step, we cloned a 6.2-kb fragment containing hcsA and
flanking sequence into pUC19 and then inserted the kanamycin cassette from
pUC18K into the Eco47III site in the hcsA gene. As a second step, we exploited
the plasmid harboring hcsB with a unique internal BamHI site and inserted the
chloramphenicol cassette from pACYC184 into this BamHI site.
Constructs were linearized and then transformed into strain RM135 made
competent using the M-IV method of Herriott et al. (16). Transformants were
selected by plating on BHI-DB agar containing kanamycin or kanamycin plus
chloramphenicol, as appropriate.
Detection and quantitation of type b polysaccharide. The presence of the type
b polysaccharide capsule on the bacterial surface was detected semiquantitatively
using a Wellcogen H. influenzae b kit (Alexon-Trend, Inc., Minnesota), which
contains latex particles coated with antibody against PRP. Levels of agglutination
were graded as nonexistent (), weak (), moderate (), and strong ().
Bacterial cellular fractions were prepared as described previously (20). In brief,
bacterial cultures were incubated to exponential phase and were pelleted by
centrifugation at 12,000  g at 4°C for 15 min. Culture supernatant was saved as
a source of extracellular released polysaccharide. To recover periplasm-associ-
ated polysaccharide, the bacterial pellet was resuspended in 0.03 M Tris (pH 7.4)
containing 3 mM EDTA and 25% (wt/vol) sucrose, incubated for 10 min at 25°C,
and pelleted by centrifugation. The pellet was rapidly resuspended in ice-cold
distilled water and incubated for 10 min at 4°C and then centrifuged at 12,000 
g at 4°C for 15 min. Supernatant, containing periplasmic polysaccharide, was
saved (41). Control assays measuring glucose-6-phosphate dehydrogenase as a
cytoplasmic marker and alkaline phosphatase as a periplasmic marker confirmed
that the periplasmic fraction was free of cytoplasmic contents.
Polysaccharide content in samples was measured by enzyme-linked immu-
nosorbent assay (ELISA) as described previously (27). The capture antibody
used for coating ELISA plates was burro anti-PRP (a generous gift from John
Robbins and Rachel Schneerson, Bureau of Biologics), and bound antigen was
detected with a mouse monoclonal anti-PRP antibody (a gift from Bruce Green,
Wyeth) and horseradish peroxidase-conjugated anti-mouse secondary antibody. The
peroxidase substrate used for supernatant and periplasm-associated polysaccharide
samples was SureBlue TMB microwell peroxidase substrate (Kirkegaard & Perry,
Gaithersburg, Maryland).
Immunoelectron microscopy. To prepare bacteria for analysis by electron
microscopy, organisms initially were fixed in 4% paraformaldehyde-0.1% glutar-
aldehyde (Polysciences Inc., Warrington, PA) in 100 mM piperazine-N,N-bis(2-
ethanesulfonic acid) (PIPES) phosphate buffer, pH 7.2, for 1 h at 4°C. Subse-
quently, samples were rinsed extensively in deionized water to remove phosphate
ions and were then stained en bloc with aqueous 2% uranyl acetate for 1 h at 4°C.
Samples were then dehydrated and infiltrated with LR Gold resin (Ted Pella,
Inc., Redding, CA) under the following conditions: 50% ethanol for 30 min at
4°C, 70% ethanol for 30 min at20°C, 90% ethanol for 30 min at20°C, 1:1 LR
Gold:ethanol for 60 min at 20°C, 3:1 LR Gold:ethanol for 60 min at 20°C,
two changes of 100% LR Gold (60 min and overnight) at 20°C, and two
changes of 100% LR Gold with 0.1% initiator (benzoin methyl ether) (4 h and
overnight) at 20°C. Samples were then embedded in fresh LR Gold resin with
initiator and polymerized at 20°C under UV light for 48 h.
Samples were sectioned with a Leica Ultracut UCT ultramicrotome (Leica
Microsystems Inc., Bannockburn, IL). Seventy- to 80-nm sections were immu-
nolabeled with mouse monoclonal anti-PRP antibody and subsequently with
18-nm-diameter colloidal gold-conjugated goat anti-mouse immunoglobulin G.
Sections were stained with uranyl acetate and lead citrate and viewed on a JEOL
1200EX transmission electron microscope (JEOL USA Inc., Peabody, MA). All
labeling experiments were processed in parallel with controls in which the pri-
mary antibody was omitted. Controls were consistently negative at the concen-
tration of gold-conjugated secondary antibodies used in these studies.
Purification of H. influenzae capsular polysaccharide. To purify capsular poly-
saccharide, periplasm-associated polysaccharide was recovered as described
above (41), and then absolute ethanol was added to achieve a final concentration
of 25% (vol/vol). After incubation for 2 h, bacterial debris was removed by
centrifugation at 25,000  g for 20 min. Polysaccharide was then precipitated by
adding absolute ethanol to a final concentration to 80% (vol/vol) and was col-
lected by centrifugation at 2,000  g for 10 min. The precipitated polysaccharide
was resuspended in distilled water, and Cetavlon (hexadecyltrimethyl ammonium
bromide) was added to the suspension to achieve a final concentration of 0.5%.
After 1 h of mixing, the polysaccharide-Cetavlon complex was collected by
centrifugation at 10,000  g for 20 min. The polysaccharide-Cetavlon complex
was resuspended in 0.3 M NaCl, and polysaccharide was recovered by centrifu-
gation at 10,000  g for 20 min. The relative quantity of polysaccharide in each
sample was determined by adding orcinol to samples and measuring the A665,
using serial dilutions of ribose as a standard.
Thin-layer chromatography. Capsular polysaccharide preparations from 1.5
liters of late-exponential-phase cultures were chromatographed on silica gel-
coated aluminum plates (Whatman) with butanol-methanol-water (5:3:2) (42).
The dried plates were stained with orcinol-ferric chloride (Bial’s reagent)
(Sigma, St. Louis, MO).
Serum resistance assay. Serum from healthy adult donors was collected,
pooled, and stored at 80°C as 100-l aliquots. Bactericidal assays were per-
formed for 30 min at 37°C using 20% serum. Percent survival was determined as
the ratio of viable counts after incubation in active serum to viable counts after
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incubation in heat-inactivated serum (56°C for 30 min to inactivate complement
function).
Virulence studies. Virulence studies using the infant rat model were per-
formed essentially as described previously (35). Sprague-Dawley albino rats used
for these experiments were purchased from Taconic Farms (Germantown, New
York). Infant rats that were 5 or 6 days old were randomized among litters.
Intraperitoneal inoculations were carried out with 100 l of bacterial suspension
adjusted to a density of 103 CFU/ml. To evaluate the development of systemic
infection, a blood sample of 10 l was obtained from a dorsal foot vein, serially
diluted in phosphate-buffered saline, and spread on chocolate agar plates to
determine the number of viable bacteria in blood. Blood samples were obtained
24 h, 48 h, and 96 h after inoculation.
RESULTS
Inactivation of H. influenzae serotype b hcsA and hcsB genes.
The genetic organization of region 3 in the H. influenzae cap b
locus is shown in Fig. 1. This region contains the hcsA and hcsB
genes, which are both transcribed away from region 2 and are
separated from each other by 259 nucleotides of noncoding
DNA. The IS1016 element that flanks the cap b locus begins 79
nucleotides downstream of the hcsB stop codon.
To define the functions of the hcsA and hcsB gene products,
we constructed three mutants of H. influenzae strain RM135,
including an hcsA null mutant with an in-frame deletion in
hcsA (RM135hcsA), an hcsB mutant with a kanamycin cassette
inserted into hcsB (RM135hcsB), and an hcsA hcsB double
mutant with a kanamycin cassette inserted into hcsA and a
chloramphenicol cassette inserted into hcsB (RM135hcsA-
hcsB). To facilitate recovery of the hcsA in-frame deletion
mutant, we introduced a kanamycin cassette into the IS1016
element downstream of the hcs region, allowing selection for
transformants on the basis of kanamycin resistance. As a con-
trol, we generated a strain with wild-type hcsA and hcsB genes
and a kanamycin cassette in the flanking IS1016 element
(RM135-IS). All mutants were confirmed to have the appro-
priate deletion or insertion using PCR and Southern analysis
(data not shown).
Localization of capsular polysaccharide in the hcsA, hcsB,
and hcsA hcsB mutants. To assess the effects of inactivation of
hcsA, of hcsB, and of both hcsA and hcsB on surface-associated
polysaccharide capsule, we examined the abilities of the parent
and mutant strains to agglutinate latex particles coated with
antibody against the H. influenzae type b capsule in semiquan-
titative assays. As shown in Table 1, wild-type RM135 and
RM135-IS agglutinated latex particles strongly. In contrast,
RM135hcsA displayed very weak agglutination, and RM135hcsB
and RM135hcsA-hcsB displayed no agglutination, results com-
parable to observations with nonencapsulated strain Rd. These
results indicate that mutations in hcsA, in hcsB, and in both
hcsA and hcsB result in diminution of surface-associated poly-
saccharide capsule.
To address whether the decrease in surface-associated poly-
saccharide capsule in the RM135hcsA, RM135hcsB, and
RM135RM135hcsA-hcsB mutants was a consequence of a
block in translocation across the outer membrane or a defect in
anchoring to the bacterial surface, we used a sandwich ELISA
to quantify polysaccharide in periplasm fractions and in culture
supernatants. In performing these assays, we used wild-type
RM135 and RM135-IS as positive controls and nonencapsu-
lated strain Rd as a negative control. As shown in Fig. 2,
examination of periplasmic fractions revealed similar quanti-
ties of polysaccharide in wild-type RM135 and RM135-IS and
in all three mutant strains. In contrast, examination of culture
supernatants revealed abundant polysaccharide in wild-type
RM135 and RM135-IS, a 60% decrease in released polysac-
charide in RM135hcsA, and no detectable released polysac-
charide in RM135hcsB and RM135hcsA-hcsB.
To extend these results, we used a murine monoclonal an-
tibody against PRP and performed immunoelectron micros-
copy on thin sections from wild-type RM135, RM135hcsA,
RM135hcsB, and Rd. As shown in Fig. 3A, wild-type strain
RM135 had immunoreactive polysaccharide in the cytoplasm,
in the periplasm, and on the bacterial surface (Fig. 3A), and
strain Rd had no appreciable immunolabeling of any com-
partment (Fig. 3B), as expected. Consistent with our latex
agglutination and ELISA results, RM135hcsA had wild-type
levels of labeling in the cytoplasm and periplasm and a
significant decrease in labeling on the bacterial surface (Fig.
3C), and RM135hcsB had appreciable labeling in the cyto-
plasm and periplasm but no clear labeling on the bacterial
surface (Fig. 3D).
Phospholipid modification of capsular polysaccharide in the
hcsA, hcsB, and hcsA hcsB mutants. Previous work has sug-
gested that N. meningitidis homologs of hcsA and hcsB may
play a role in substitution of a 1,2-diacylglycerol lipid moiety at
the reducing end of the N. meningitidis serogroup B capsule
polymer (13). To assess whether the hcsA and hcsB gene prod-
ucts affect lipidation of the type b polysaccharide, we purified
periplasmic polysaccharide from wild-type RM135, RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB and then compared these
polysaccharide samples by thin-layer chromatography (lip-
idated and nonlipidated polysaccharides migrate differently on
thin-layer chromatography plates). As shown in Fig. 4, all poly-
saccharide samples migrated in identical fashion, arguing
against any defect in lipid modification of polysaccharide from
the mutant strains. To confirm this result, we separated sam-
ples by using a Tris-borate-buffered polyacrylamide gel elec-
trophoresis system and again observed no difference in migra-
tion (data not shown).
TABLE 1. Latex agglutination of wild-type RM135, RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB with latex particles







a PRP is the H. influenzae type b polysaccharide.
b Levels of agglutination were graded as nonexistent (), weak (), moderate
(), and strong ().
FIG. 1. Diagram of region 3 of the H. influenzae type b cap b locus,
showing the locations of hcsA and hcsB relative to region 2 and the
flanking IS1016 element.
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Sensitivity to serum complement of the hcsA, hcsB, and hcsA
hcsB mutants. Previous studies have demonstrated the impor-
tance of surface-associated capsule in H. influenzae resistance
to complement-mediated killing (17, 25, 38). With this infor-
mation in mind, we compared wild-type RM135, RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB in 30-minute serum resis-
tance assays, using RM135-IS and Rd as controls. Using the
ratio of viable counts in 20% normal human serum to viable
counts in 20% heat-inactivated human serum as a measure of
serum resistance, wild-type RM135 and RM135-IS were80%
to 100% resistant (Fig. 5). In contrast, the RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB mutants were completely
susceptible to complement-mediated killing, analogously to
strain Rd (Fig. 5). These observations are consistent with our
quantitative latex agglutination and ELISA results and suggest
that a certain threshold level of surface-associated capsule is
required for serum resistance.
Virulence in the infant rat bacteremia model by the hcsA,
hcsB, and hcsA hcsB mutants. To investigate the role of hcsA
and hcsB in virulence, we compared wild-type RM135,
RM135hcsA, RM135hcsB, and RM135hcsA-hcsB in the infant
rat bacteremia model in two independent experiments using an
intraperitoneal route of infection. In experiment 1, among rats
infected with wild-type strain RM135, 50% were dead after
72 h and 70% were dead after 96 h (Fig. 6A). All rats infected
with either RM135hcsA or RM135hcsB survived, indicating
that inactivation of either hcsA or hcsB attenuates virulence.
One pup infected with RM135hcsA-hcsB died, but this pup was
much smaller than its littermates, raising the possibility that
factors other than infection contributed to death. In experi-
ment 2, results were similar, although mortality among rats
infected with wild-type RM135 was generally higher (Fig. 6B).
In this experiment, infection with wild-type RM135 resulted in
death for 70% of rats after 48 h and 100% of rats after 72 h. All
rats infected with RM135hcsA, RM135hcsB, or RM135hcsA-
hcsB survived during this experiment.
To complement our assessment of mortality, we collected
blood samples at 24, 48, and 96 h after inoculation and deter-
mined the magnitude of bacteremia in surviving animals. As
shown in Table 2, animals infected with wild-type RM135 had
high numbers of CFU per ml of blood at all time points during
both experiments. In contrast, none of the animals infected
with RM135hcsA, RM135hcsB, or RM135hcsA-hcsB had bac-
terial counts higher than the limit of detection (100 CFU per
ml of blood) in either experiment.
These observations are consistent with our quantitative latex
agglutination and ELISA results and our serum resistance as-
says and suggest that a certain threshold level of surface-asso-
ciated capsule is required for virulence in animals.
DISCUSSION
The H. influenzae type b cap b locus contains three func-
tional regions, designated region 1, region 2, and region 3 (19).
Recent work has established that region 3 contains genes,
called hcsA and hcsB, with homology to genes in a number of
other encapsulated bacteria (32). In this study, we examined
the function of hcsA and hcsB. Based on analysis of hcsA, hcsB,
and hcsA hcsB mutants, we found that both the hcsA and the
hcsB gene products are required for efficient transport of cap-
sular polysaccharide across the outer membrane. Consistent
with the decrease in surface-associated polysaccharide in these
mutants, we observed abrogation of serum resistance and elim-
ination of virulence in experimental rats.
The hcsA and hcsB gene products share homology with gene
products in other pathogenic bacteria that express group II
capsules, including N. meningitidis, E. coli K1, E. coli K5, M.
haemolytica, P. multocida A:1, P. multocida B:2, B. mallei, and
B. pseudomallei (4, 7, 10, 13, 22, 29, 34). In some cases, the
hcsA and hcsB homologs are present as an independent unit in
a distinct region of the capsule gene complex, which is analo-
gous to the arrangement in H. influenzae (for example, lipA and
lipB in region B in N. meningitidis). In other cases the hcsA and
hcsB homologs are interspersed among other capsule-related
genes, as illustrated by the kpsS and kpsC genes at the end of
the kpsFEDUCS gene cluster in region 1 in E. coli K1 and E.
coli K5.
In initial studies of the N. meningitidis lipA and lipB genes,
FIG. 2. Quantity of PRP (the H. influenzae type b polysaccharide capsule) in the periplasms and culture supernatants of wild-type RM135,
RM135hcsA, and RM135hcsB and of RM135hcsA-hcsB, RM135-IS, and Rd. PRP content was measured by ELISA, and values were compared to
values for wild-type RM135, which were set at 100%. RM135-IS is a control strain that contains intact hcsA and hcsB genes and harbors a
kanamycin cassette in the IS1016 element downstream of hcsB (analogous to the kanamycin cassette in the IS1016 element in strain RM135hcsA).
Rd is a control strain that lacks capsule genes.
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the cloned meningococcal capsule gene complex (cps) was
examined in E. coli K-12 (13). In this heterologous back-
ground, deletion of the lipA and lipB genes resulted in intra-
cellular accumulation of capsule polymers lacking a phospho-
lipid substitution, leading to the proposal that the lipA and lipB
gene products mediate polysaccharide lipidation prior to trans-
port of capsule polymers to the bacterial surface (13). How-
ever, more recently, Tzeng et al. generated lipA and lipB
mutations in N. meningitidis strain NMB and observed intra-
cellular accumulation of capsule polymers that were clearly
lipidated (40). Interestingly, studies of E. coli kpsS and kpsC
have also yielded mixed results. In particular, in E. coli K-12
carrying the complete K5 capsule gene cluster on a plasmid, a
kpsS insertion mutation and a kpsC deletion mutation resulted
in cytoplasmic accumulation of capsule polysaccharide lacking
the phosphatidic-3-deoxy-manno-2-octulosonic acid substitu-
tion (5). In contrast, Cieslewicz and Vimr found that Tn10
insertion mutations in either kpsC or kpsS in the chromosome
in an E. coli K-12-K1 hybrid strain were associated with intra-
cellular accumulation of capsule polymers with wild-type lip-
idation (8). Together, these observations raise the possibility
that the function of the lipA and lipB and the kpsC or kpsS
genes may be altered in the K-12 genetic background. In the
present study, we generated mutations in hcsA and hcsB in H.
influenzae directly and observed accumulation of polysaccha-
ride in the periplasm, suggesting a block in transport across the
FIG. 3. Immunoelectron micrographs of wild-type RM135, Rd, RM135hcsA, and RM135hcsB. PRP was immunolabeled with mouse mono-
clonal anti-PRP antibody followed by 18-nm colloidal gold-conjugated goat anti-mouse immunoglobulin G. (A) Wild-type RM135. (B) Rd.
(C) RM135hcsA. (D) RM135hcsB. Bars, 0.2 m.
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outer membrane. Based on thin-layer chromatography and
electrophoretic mobility of polysaccharide purified from the
periplasm, the hcsA and hcsB mutations had no effect on lip-
idation.
Fractionation of polysaccharide in the hcsA, hcsB, and hcsA
hcsB mutants revealed reduced quantities of surface-localized
polysaccharide with inactivation of hcsA and a complete ab-
sence of surface-localized polysaccharide with inactivation of
either hcsB alone or hcsA and hcsB together. These results
suggest that the HcsA and HcsB proteins have distinct func-
tions involved in transport of polysaccharide from the
FIG. 4. Thin-layer chromatography of polysaccharide samples
purified from the periplasms of wild-type RM135, RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB. For each sample, similar quanti-
ties of polysaccharide were spotted onto a gel-coated aluminum plate,
and chromatography was performed with butanol-methanol-water (5:
3:2). Polysaccharide was visualized by staining with orcinol-ferric chlo-
ride. The arrow indicates the polysaccharide.
FIG. 5. Serum resistance of wild-type RM135, RM135hcsA, and
RM135hcsB and of RM135hcsA-hcsB, RM135-IS, and Rd. Samples
were incubated in 20% human serum for 30 min at 37°C. Percent
survival was determined as the ratio of viable counts after incubation
in active serum to viable counts after incubation in heat-inactivated
serum. RM135-IS is a control strain that contains intact hcsA and hcsB
genes and harbors a kanamycin cassette in the IS1016 element down-
stream of hcsB (analogous to the kanamycin cassette in the IS1016
element in strain RM135hcsA). Rd is a control strain that lacks capsule
genes.
FIG. 6. Virulence of wild-type RM135, RM135hcsA, RM135hcsB,
and RM135hcsA-hcsB in infant rats after intraperitoneal inoculation.
Survival was measured at 24, 48, 72, and 96 h after inoculation.
(A) Plot of the results of experiment 1. (B) Plot of the results of
experiment 2.
TABLE 2. Bacteremia in infant rats after intraperitoneal





24 h 48 h 96 h
1 RM135 1.5  107 3.6  108 7.0  104
RM135hcsA 100 100 100
RM135hcsB 100 100 100
RM135hcsA-hcsB 100 100 100
2 RM135 8.0  107 9.0  108 ND
RM135hcsA 100 100 100
RM135hcsB 100 100 100
RM135hcsA-hcsB 100 100 100
a Numbers represent geometric means of the numbers of CFU/ml of blood.
Limit of detection was 100 CFU/ml. ND, not done.
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periplasm to the bacterial surface. In considering possible
functions, it is notable that the predicted amino acid sequences
of HcsA and HcsB lack typical signal sequences, arguing either
that they are cytoplasmic proteins or that they are localized in
the membrane or the periplasm via a Sec-independent mech-
anism. Future studies of HcsA and HcsB will assess their cel-
lular localization and their relationship to the ABC transporter
comprised of the H. influenzae bexA, bexB, bexC, and bexD gene
products.
In approximately 98% of H. influenzae type b isolates, the
cap region contains two tandem copies of the cap b locus,
including one copy that is intact and a second copy that is
complete except for a partial deletion of bexA (1). In the
remaining 2% of H. influenzae type b isolates, a single copy of
the cap b locus is present (1). In earlier studies, Kroll and
Moxon compared capsule production in strains with one copy
or two copies of the cap b locus and observed a gene dosage
effect, with twice as much polysaccharide capsule associated
with two copies of the cap b locus (20). Interestingly, despite
differences in capsule production, all strains were capable of
producing sustained bacteremia and meningitis in the infant
rat model, suggesting that one copy of the cap b locus is
sufficient for virulence (20). In this context, it is noteworthy
that our studies of RM135hcsA revealed appreciable quantities
of surface-associated polysaccharide but complete sensitivity to
complement-mediated killing and avirulence in infant rats.
These findings suggest that a certain threshold level of poly-
saccharide capsule on the bacterial surface is required for
intravascular survival and virulence.
To summarize, our results demonstrate that the hcsA and
hcsB genes in H. influenzae type b are essential for efficient
transport of capsular polysaccharide across the bacterial outer
membrane and for virulence in experimental animals. Given
that homologs of hcsA and hcsB are present in many encap-
sulated bacterial pathogens, the hcsA and hcsB gene products
may be viable targets for antimicrobial development.
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